article thumbnail

Industry Briefs November 2022

PM360

The two retail pharmacy giants have announced their intention to settle lawsuits regarding inappropriate opioid prescriptions at $5 billion each. billion to local governments and about $130 million to Native American tribes over a decade. billion to governments and $155 million to tribes over 15 years. Local and U.S.

article thumbnail

How to Market to Doctors, Physicians, and Other Health Care Professionals

Healthcare Success

Here are two ways to define your doctor audience: Target your best prospects Enhance your database to target more precisely. Target Your Best Prospects. The best way to target your best prospects is to define the type of clients you want to acquire by assessing your existing customer base. More data is always better.

Doctors 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Our abysmal health care system

World of DTC Marketing

Researchers found that physicians don’t think very highly of health insurance companies and believe they’re putting patients at risk with policies such as prior authorizations ahead of filling prescriptions. Pricing for prescription drugs is about as transparent as airline fares.

Insurance 263
article thumbnail

US government plans proposal to push down Medicaid drug prices

Pharmaceutical Technology

The US Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) have announced steps to push down prescription drug prices under Medicaid as part of a new proposal. The CMS will not use this process to limit access to any of the surveyed medicines, based on the fact sheet.

article thumbnail

FDA AdCom votes unanimously in favour of OTC oral contraceptive

Pharmaceutical Technology

The FDA approved Opill for prescription use in 1973. But this was followed by a lower court decision that limited access to Mifeprex, which was later overturned by the US Supreme Court ruling upheld the FDA’s rules governing the sale of the drug. The therapy only contains the hormone progestin and is taken once daily.

FDA 52
article thumbnail

OTC Narcan will cost ‘less than $50’, company says

Pharmaceutical Technology

Public interest groups including government agencies, harm reduction groups, and emergency responders pay less than $50 out of pocket for one carton of the spray, according to Emergent. On March 29, 2023, the US Food and Drug Administration (FDA) granted approval that made Narcan the opioid treatment drug to be sold without a prescription.

article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

Ex-Novartis sales representative Steven Camburn filed a whistleblower case that claimed Novartis had paid doctors up to $3,500 to participate in educational speaker programs to increase the promotion and prescription of Gilenya. However, Novartis did not get the same reception while facing similar allegations in Greece. Novartis vs Greece.